首页> 美国卫生研究院文献>Springer Open Choice >Highly Sensitive MoS2–Indocyanine Green Hybrid for Photoacoustic Imaging of Orthotopic Brain Glioma at Deep Site
【2h】

Highly Sensitive MoS2–Indocyanine Green Hybrid for Photoacoustic Imaging of Orthotopic Brain Glioma at Deep Site

机译:高灵敏度的MoS2-吲哚菁绿杂化物用于深位原位脑神经胶质瘤的光声成像

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Photoacoustic technology in combination with molecular imaging is a highly effective method for accurately diagnosing brain glioma. For glioma detection at a deeper site, contrast agents with higher photoacoustic imaging sensitivity are needed. Herein, we report a MoS2–ICG hybrid with indocyanine green (ICG) conjugated to the surface of MoS2 nanosheets. The hybrid significantly enhanced photoacoustic imaging sensitivity compared to MoS2 nanosheets. This conjugation results in remarkably high optical absorbance across a broad near-infrared spectrum, redshifting of the ICG absorption peak and photothermal/photoacoustic conversion efficiency enhancement of ICG. A tumor mass of 3.5 mm beneath the mouse scalp was clearly visualized by using MoS2–ICG as a contrast agent for the in vivo photoacoustic imaging of orthotopic glioma, which is nearly twofold deeper than the tumors imaged in our previous report using MoS2 nanosheet. Thus, combined with its good stability and high biocompatibility, the MoS2–ICG hybrid developed in this study has a great potential for high-efficiency tumor molecular imaging in translational medicine.Electronic supplementary materialThe online version of this article (10.1007/s40820-018-0202-8) contains supplementary material, which is available to authorized users.
机译:光声技术与分子成像相结合是一种准确诊断脑胶质瘤的高效方法。为了在更深的部位检测神经胶质瘤,需要具有更高的光声成像灵敏度的造影剂。在本文中,我们报道了一种MoS2-ICG杂化体,其中吲哚菁绿(ICG)与MoS2纳米片的表面共轭。与MoS2纳米片相比,该杂化物显着增强了光声成像灵敏度。这种共轭导致在宽广的近红外光谱范围内具有极高的光吸收率,ICG吸收峰的红移以及ICG的光热/光声转换效率提高。通过使用MoS2-ICG作为原位神经胶质瘤的体内光声成像的造影剂,可以清楚地观察到小鼠头皮下方3.5毫米的肿瘤块,其深度比我们先前使用MoS2纳米片报道的肿瘤深两倍。因此,结合其良好的稳定性和高生物相容性,本研究开发的MoS2-ICG杂化物在转化医学中具有高效肿瘤分子成像的巨大潜力。电子补充材料本文的在线版本(10.1007 / s40820-018- 0202-8)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号